Inventor

Brian A. Sherer

Inventor
Nashua, NH, US

Overview

28→
Patents
2001–2021
Patent span
Human necessities
Primary field (CPC A)

Patents· 28 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

A61Pprimary
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations36%
C07DHeterocyclic compounds34%
A61KPreparations for medical, dental or toiletry purposes23%
C07CAcyclic or carbocyclic compounds5%
C07BGeneral methods of organic chemistry1%
PatentTitleYear
11,098,041Heteroaryl compounds as BTK inhibitors and uses thereof202110,947,213TLR7/8 antagonists and uses thereof202110,947,214TLR7/8 antagonists and uses thereof202110,836,750TLR7/8 antagonists and uses thereof202010,793,553TLR7/8 antagonists and uses thereof202010,696,649TLR7/8 antagonists and uses thereof202010,544,122TLR7/8 antagonists and uses thereof202010,428,080TBK/IKK inhibitor compounds and uses thereof201910,399,957TLR7/8 antagonists and uses thereof201910,377,745Heterocyclic compounds as NaV channel inhibitors and uses thereof201910,329,297Compounds for the inhibition of indoleamine-2,3-dioxygenase201910,253,023Heteroaryl compounds as BTK inhibitors and uses thereof20199,988,391TBK/IKK inhibitor compounds and uses thereof20189,771,370'Compounds for the inhibition of indoleamine-2,3-dioxygenase'20179,676,757'Heterocyclic compounds as NaV channel inhibitors and uses thereof'20178,569,484'Heterocyclic urea derivatives and methods of use thereof'20138,399,489'Antibacterial piperdine derivatives'20138,283,361'Heterocyclic urea derivatives and methods of use thereof'20128,071,605'Piperidine compounds for use in the treatment of bacterial infections'20117,674,801'Alkyl urea substituted pyridines'20107,262,208'Hydroxypropyl amides for the treatment of Alzheimer\'s disease'20077,244,755'Hydroxypropylamines'20076,919,377'Cyclohexylamine derivative as subtype selective NMDA receptor antagonists'20056,828,341'Cyclohexylamine derivatives as subtype selective N-Methyl-D-Aspartate antagonists'20046,794,402'Bicyclic cyclohexylamines and their use as NMDA receptor antagonists'20046,765,022'Cyclohexylamine derivatives as subtype selective nmda receptor antagonists'20046,683,101'Bicyclic cyclohexylamines and their use as NMDA receptor antagonists'20046,242,461'Use of aryl substituted azabenzimidazoles in the treatment of HIV and AIDS related diseases'2001

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

2001–2004Based in Clifton Park, NY, US· patent location history
2004–2005Patents assigned to WARNER LAMBERT CO (5)· patent assignee history
2004–2007Based in Ballston Spa, NY, US· patent location history
2010–2013Patents assigned to ASTRAZENECA AB (5)· patent assignee history
2010–2013Based in Waltham, MA, US· patent location history
2011–2013Patents assigned to HILL PAMELA (3)· patent assignee history
2011–2013Patents assigned to SHERER BRIAN (3)· patent assignee history
2013–2021Based in Nashua, NH, US· patent location history
2017–2021Patents assigned to MERCK PATENT GMBH (15)· patent assignee history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
MERCK PATENT GMBH152017–2021
ASTRAZENECA AB52010–2013
WARNER LAMBERT CO52004–2005
HILL PAMELA32011–2013
SHERER BRIANself32011–2013
Locations
LocationPatentsSpan
Nashua, NH, US162013–2021
Waltham, Massachusetts, US42010–2013
Ballston Spa, New York, US42004–2007
Clifton Park, New York, US42001–2004